These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9964800)

  • 21. Absorbing-state phase transitions with extremal dynamics.
    Dickman R; Garcia GJ
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Jun; 71(6 Pt 2):066113. PubMed ID: 16089826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Branching process in a stochastic extremal model.
    Manna SS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2009 Aug; 80(2 Pt 1):021132. PubMed ID: 19792102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal persistence exponents in an extremally driven system.
    Head DA
    Phys Rev E Stat Nonlin Soft Matter Phys; 2002 Feb; 65(2 Pt 2):027104. PubMed ID: 11863695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic critical approach to self-organized criticality.
    Laneri K; Rozenfeld AF; Albano EV
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Dec; 72(6 Pt 2):065105. PubMed ID: 16485999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Random networks created by biological evolution.
    Slanina F; Kotrla M
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Nov; 62(5 Pt A):6170-7. PubMed ID: 11101948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are critical phenomena relevant to large-scale evolution?
    Solé RV; Bascompte J
    Proc Biol Sci; 1996 Feb; 263(1367):161-8. PubMed ID: 8728980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scaling theory of depinning in the Sneppen model.
    Maslov S; Paczuski M
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 1994 Aug; 50(2):R643-R646. PubMed ID: 9962165
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
    Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prostaglandin analogs on blood flow velocity and resistance in the ophthalmic artery of rabbits.
    Giannico AT; Lima L; Shaw GC; Russ HH; Froes TR; Montiani-Ferreira F
    Arq Bras Oftalmol; 2016 Feb; 79(1):33-6. PubMed ID: 26840164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epi-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma.
    Hsu JL; Liu FL; Hsu LC; Chang HS; Leu WJ; Yu CC; Chang WL; Chen IS; Kung FL; Guh JH
    Oncotarget; 2015 Sep; 6(27):24032-46. PubMed ID: 26125228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family.
    Krajewski S; Krajewska M; Reed JC
    Cancer Res; 1996 Jun; 56(12):2849-55. PubMed ID: 8665525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
    Baudouin C; Riancho L; Warnet JM; Brignole F
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
    Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
    Ammar DA; Kahook MY
    Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost.
    Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
    Clin Exp Ophthalmol; 2015 Mar; 43(2):164-72. PubMed ID: 25041649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes.
    Lee HJ; Jun RM; Cho MS; Choi KR
    Cutan Ocul Toxicol; 2015; 34(3):195-202. PubMed ID: 25265260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
    Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
    Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.